NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/28/2021
Back to search
Official data from USPTO
FAPON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
04/28/2021
Trademark type
Word
Nice classes
1, 5, 10
Filing date
07/28/2009
Registration date
03/08/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2021
Last transaction
04/28/2021
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SHENZHEN, CN
Examiner
LAM, HAI-LY
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
FAPON BIOTECH INC.
Shenzhen Feipeng Kechuang partnership (L.P.)
FAPON BIOTECH INC.
FAPON BIOTECH INC.
Representatives
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparationsother than for medical or veterinary purposes; biological preparationsother than for medical or veterinary purposesantibodiesantigenspeptidesenzymeslysatesvectorslipidsstem cellscell strainsstrainstags and markerstag and marker antibodiesantigens and proteinsall for research purposes; cultures of microorganisms other than for medical and veterinary use; biochemical catalysts; chemical reagents for non-medical purposes
Class 5
Vaccines; biological preparations for medical purposes; diagnostic preparations for medical purposes; bacterial and bacteriological preparations for medical or veterinary purposes; blood derivativeshematology calibrators and controlsblood plasmablood substitutes for human or veterinary usecoagulation factorimmunoglobulintissue type plasminogen activatorC-reactive proteinhuman antithrombin; veterinary preparations for treatment of intestinal bacteria; anti-infective products for veterinary use; pharmaceutical preparations for the treatment of addiction in the fields of smoking or drugs; pharmaceutical preparations for the treatment of urinary incontinence; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of cerebrovascular diseases and disorders; pharmaceutical preparations for the treatment of anxietydepressioninsomniacognitive disorders and diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of menopausal symptoms and disorders; pharmaceutical preparationsanti-infective preparations; pharmaceutical preparationsanti-viral preparations; pharmaceutical preparationsimmunological preparations; pharmaceutical preparationsanalgesic preparations; pharmaceutical preparationsantiemetic preparations; pharmaceutical preparationsvaccine preparations; biochemical preparations for medical or veterinary purposes; bacterial preparations for medical and veterinary use; none of the foregoing being ophthalmic preparations or otorhinolaryngological preparations
Class 10
Testing apparatus for medical purposesskin allergy testing apparatus; testing apparatus for medical purposesblood glucose testing apparatus in the nature of blood glucose meter and blood drawing apparatus; apparatus and instruments for medical and veterinary diagnosisequipments and devices in the nature of immuno analysersnucleid acid analysers; bacteriologic analysersmicrobiologic analysers used for testing or for manual or for automated testing in medical and clinical applications; medical diagnostic apparatus for medical purposesultrasonic and magnetic resonance imaging diagnostic apparatusX-ray computer tomography scannerscomputed tomography (CT) apparatusdiagnostic X-ray apparatus; blood testing apparatus
Publications
History of USPTO decisions and trademark events.
51 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
04/28/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/28/2021
ES71
TEAS SECTION 71 RECEIVED
03/05/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/31/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/18/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
05/19/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/20/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/20/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/20/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/20/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/08/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/15/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/15/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/27/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/17/2017
71AG
REGISTERED-SEC.71 ACCEPTED
08/17/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/17/2017
ES71
TEAS SECTION 71 RECEIVED
07/28/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/24/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/15/2011
FIMP
FINAL DISPOSITION PROCESSED
06/15/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/08/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2011
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
01/07/2011
CHPB
POST PUBLICATION AMENDMENT - ENTERED
12/02/2010
APET
ASSIGNED TO PETITION STAFF
11/10/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/09/2010
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/09/2010
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
09/16/2010
PUBO
PUBLISHED FOR OPPOSITION
08/24/2010
NPUB
NOTICE OF PUBLICATION
08/04/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/22/2010
ALIE
ASSIGNED TO LIE
07/22/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2010
RFNP
REFUSAL PROCESSED BY IB
01/01/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/09/2009
RFRR
REFUSAL PROCESSED BY MPU
12/09/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/07/2009
CNRT
NON-FINAL ACTION WRITTEN
12/06/2009
MAFR
APPLICATION FILING RECEIPT MAILED
12/05/2009
DOCK
ASSIGNED TO EXAMINER
12/01/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2009
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
11/30/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/26/2009
Continuous trademark protection
Get notified about every new filing that threatens FAPON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.